TWINBEECH CAPITAL LP - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWINBEECH CAPITAL LP ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$929,129
-63.2%
99,160
-8.6%
0.02%
-64.7%
Q1 2023$2,524,958
-20.8%
108,507
-34.4%
0.05%
-39.3%
Q3 2022$3,190,000
+468.6%
165,460
+658.9%
0.08%
+236.0%
Q1 2022$561,000
-77.0%
21,802
-61.0%
0.02%
-85.5%
Q3 2021$2,436,00055,9740.17%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders